complicated 发表于 2025-3-21 16:12:05

书目名称Breast Disease影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0190592<br><br>        <br><br>书目名称Breast Disease读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0190592<br><br>        <br><br>

无政府主义者 发表于 2025-3-21 22:46:47

http://reply.papertrans.cn/20/1906/190592/190592_2.png

shrill 发表于 2025-3-22 00:34:27

http://reply.papertrans.cn/20/1906/190592/190592_3.png

nugatory 发表于 2025-3-22 04:45:15

http://reply.papertrans.cn/20/1906/190592/190592_4.png

药物 发表于 2025-3-22 12:13:21

http://reply.papertrans.cn/20/1906/190592/190592_5.png

Forsake 发表于 2025-3-22 16:00:25

http://reply.papertrans.cn/20/1906/190592/190592_6.png

牵连 发表于 2025-3-22 17:36:43

Adjuvant Systemic Therapy: Endocrine Therapyll breast cancers. Adjuvant endocrine therapy is a pivotal component of treatment for women with hormone receptor-positive early-stage breast cancer; it delays local and distant relapse and prolongs survival. Patients with ER- and/or PR-positive invasive breast cancers should be considered for adjuv

multiply 发表于 2025-3-23 00:01:56

http://reply.papertrans.cn/20/1906/190592/190592_8.png

矛盾 发表于 2025-3-23 01:47:56

Adjuvant Therapy for HER2-Positive Early Breast Cancers stories in the history of breast cancer. The development of HER-2-targeted therapies has changed the natural history of HER-2-positive breast cancer dramatically in the past two decades. Success in the metastatic setting has been subsequently translated into improved clinical outcomes for women wi

thrombus 发表于 2025-3-23 05:39:41

http://reply.papertrans.cn/20/1906/190592/190592_10.png
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: Breast Disease; Management and Thera Adnan Aydiner,Abdullah İgci,Atilla Soran Book 20161st edition Springer International Publishing Switze